LowMarketSignal detected 9d ago

BASF registers Integral Pro biological seed treatment in France ahead of 2026 EU rollout

Seed Treatment Market 2025 to 2032: Crop Protection Innovation, Biological Transition and Tight Supply Economics →
What Changed

BASF secured registration for Integral Pro in France in November 2025 for sunflower crops, targeting an EU-wide rollout starting in the 2026 sowing season. Field trials conducted from 2022 to 2024 showed an average yield increase of 3.5 dt/ha compared to untreated seeds. Additionally, major input suppliers including Bayer and Nufarm are expanding biological offerings with product launches like Ibisio, Yoalo, Susteed, and Pretium SDS.

At a Glance
Severity
Low
Likelihood
High
Spend Exposed
-

Severity: how big the impact would be if this plays out.

Likelihood: how probable the engine judges it is to happen or persist.

Spend exposed: the share of your annual category spend this flags.

Add your annual spend to quantify exposure:
$
Confidence
90%
Recommended Actions 1

Evaluate hybrid biological-chemical seed treatment programs for upcoming sowing cycles

Commercial entry of proven microbial treatments offers opportunities to enhance yield potential and transition toward integrated crop protection strategies.

Evidence 3
techsciresearch.com

Source · techsciresearch.com

1. Product Overview 1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & V

openpr.com

Source · openpr.com

# Biological Seed Treatment Market Gains Momentum as BASF's Integral Pro Delivers 3.5 dt/ha Average Yield Increase in EU Sunflower Trials BASF's November 2025 registration of Integral Pro in France for sunflower marks a significant step in the commercialization of biological seed treatments in Europe. Based on Bacillus amyloliquefaciens MBI600, the biological fungicide is scheduled for EU-wide av